Medicine
Zyvox 200 mg/100 mL injection
Zyvox 200 mg/100 mL injection is a prescription medicine containing Linezolid for intravenous use, marketed by Hp Halden Pharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Protect infusion bags from freezing. Store at 25°C (77°F). Protect from light…
Key facts
- Active ingredient (INN)
- Linezolid
- Brand
- Zyvox
- Strength
- 200 mg/100 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 100 mL
- Marketing authorisation holder
- Hp Halden Pharma
- Manufacturer
- Hp Halden Pharma
- Origin register
- US FDA, United States
- Storage
- Protect infusion bags from freezing. Store at 25°C (77°F). Protect from light. Keep bottles tightly closed to protect from moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01XX08 Linezolid
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 4 June 2018
- Identifiers
- RxCUI 1662278, 1662280DailyMed set ID ce57225b-4580-442b-8c48-8045297cbb50NDC 66298-5137Application NDA021131
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 mL in 1 bag | 66298-5137-1 | Hp Halden Pharma | 4 June 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 18 April 2000 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Linezolid 200 mg/100 mL injection.
Other strengths and forms of Linezolid
Clinical summary
Linezolid is an oxazolidinone antibacterial indicated in adults and children for the treatment of infections caused by susceptible Gram-positive bacteria, among other approved uses. It is available as tablets, injection and oral suspension for intravenous use. MedsAcross supplies Linezolid for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about LinezolidFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Zyvox prescribing information (Pharmacia & Upjohn) · U.S. National Library of Medicine, DailyMed
Need Zyvox 200 mg/100 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.